Shareholding Pattern For December 31, 2014
Glenmark Pharmaceuticals Ltd has informed BSE about the Shareholding Pattern as on December 31, 2014.08-01-2015
08-01-2015
Glenmark Pharmaceuticals Ltd reply to clarification sought by the exchange
The Exchange had sought clarification from Glenmark Pharmaceuticals Ltd with respect to news article appearing in The Financial Express on January 7, 2015 titled "Glenmark Pharma wins patent war with Abbott" Glenmark Pharmaceuticals Ltd replied stating "The Company confirms the news item "Glenmark Pharma wins patent war with Abbott" which has been independently published by the Financial Express on 7th January'15....07-01-2015
Clarification sought from Glenmark Pharmaceuticals Ltd
The Exchange has sought clarification from Glenmark Pharmaceuticals Ltd with respect to news article appearing in The Financial Express on January 07, 2015 titled "Glenmark Pharma wins patent war with Abbott."The reply is awaited.07-01-2015
Disclosure of Voting results of Postal Ballot (Clause 35A)
Glenmark Pharmaceuticals Ltd has informed BSE regarding the details of Voting results of Postal Ballot, under Clause 35A.31-12-2014
Clarifies on News item
With reference to the news item appearing in the financial daily titled "Glenmark to out-license molecule for pain management", Glenmark Pharmaceuticals Ltd has Clarified to BSE as under""As a part of its business, the Company enters into discussions with various Pharmaceutical Companies (Interested licensees) with respect to its innovative product pipeline. Such discussions are mostly exploratory and may or may not result in a business deal....29-12-2014
Proceedings of Court Convened Meeting
Glenmark Pharmaceuticals Ltd has submitted to BSE a copy of the proceedings of the Court Convened Meeting of the Equity Shareholders of the Company held on November 19, 2014.16-12-2014
Outcome of Operations Committee Meeting
Glenmark Pharmaceuticals Ltd has informed BSE that the Operations Committee of the Board of Directors of the Company, at its Meeting held on December 03, 2014 allotted 4,000 shares to the employees of the Company on exercise of options granted to them pursuant to ESOS 2003.03-12-2014
Newspaper Advertisement for Result of Postal Ballot/E-Voting
Glenmark Pharmaceuticals Ltd has submitted to BSE a copy of the newspaper advertisement regarding declaration of Result of Postal Ballot/E-Voting.28-11-2014
Notice of Postal Ballot
Glenmark Pharmaceuticals Ltd has informed BSE that the members of the Company will consider to approve the resolutions, by way of Postal Ballot.28-11-2014
Resignation of Director
Glenmark Pharmaceuticals Ltd has informed BSE that Mr. Hocine Sidi Said, Director of the Company has resigned from the Board with effect from November 25, 2014.26-11-2014